Showing results (651-660 of 782) with videos related to

Sort By:
Pageof 79
Blood|February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
The New England Journal of Medicine|June 27, 2003
A phase 2 study of bortezomib in relapsed, refractory myelomaPaul G Richardson, Bart Barlogie, James Berenson, et al.
Blood Advances|November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
Blood|August 16, 2005
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myelomaSagar Lonial, Edmund K Waller, Paul G Richardson, et al.
Blood|October 20, 2005
Antimyeloma activity of heat shock protein-90 inhibitionConstantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Lenalidomide and rituximab in Waldenstrom's macroglobulinemiaSteven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
Blood|March 6, 2023
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myelomaYao Yao, Jessica Fong Ng, Woojun Daniel Park, et al.
Cancer Research|April 19, 2007
Proteomic analysis of waldenstrom macroglobulinemiaEvdoxia Hatjiharissi, Hai Ngo, Alexey A Leontovich, et al.
Molecular Cancer Therapeutics|April 5, 2012
Adenosine A2A and beta-2 adrenergic receptor agonists: novel selective and synergistic multiple myeloma targets discovered through systematic combination screeningRichard J Rickles, Winnie F Tam, Thomas P Giordano, et al.
Nature Genetics|March 31, 2009
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancerGijs van Haaften, Gillian L Dalgliesh, Helen Davies, et al.
Pageof 79